Literature DB >> 32903934

Thymol-Induced Chemical Leukoderma Successfully Treated with 308-Nanometer Excimer Laser.

Maximillian A Weigelt1, Alexander T Herbst1, Antonella Tosti1, Hadar Lev-Tov1.   

Abstract

INTRODUCTION: Chemical leukoderma (CL) is an acquired depigmenting disorder caused by repeated exposure to chemical compounds. Thymol is a phenol derivative used as a preservative or antiseptic in many commercially available products. Here, we present the second reported case of CL caused by a thymol-containing compound. CASE
PRESENTATION: A 48-year-old woman presented with a 4-month history of depigmentation of the nail folds of all ten fingers. This occurred after 1 month of twice-daily application of a thymol-containing compound intended for the removal of gel nails. No improvement was noted after the product was discontinued. There was no family history of vitiligo or other autoimmune disorders. On physical exam, depigmentation of all ten proximal and lateral nail folds was seen, with accentuation on Wood's lamp exam. Partial re-pigmentation was achieved after 32 treatments with 308-nm excimer laser. DISCUSSION: A thorough history and physical exam are instrumental in differentiating CL from other causes of depigmentation. Avoidance of the offending agent is an essential part of management. It is important to note that many cosmetic products are not tightly regulated by the FDA. Excimer laser is an effective treatment for CL with a favorable side-effect profile.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Chemical; Contact; Depigmentation; Laser; Leukoderma

Year:  2020        PMID: 32903934      PMCID: PMC7445539          DOI: 10.1159/000507899

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  7 in total

1.  Treatment of chemical leukoderma using a 308-nm excimer laser.

Authors:  Elizabeth Ghazi; Jennifer Ragi; Sandy Milgraum
Journal:  Dermatol Surg       Date:  2012-06-08       Impact factor: 3.398

Review 2.  Applications of the Excimer Laser: A Review.

Authors:  Sarah Beggs; Jack Short; Monica Rengifo-Pardo; Alison Ehrlich
Journal:  Dermatol Surg       Date:  2015-11       Impact factor: 3.398

Review 3.  Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions.

Authors:  Mohammed D Saleem; Elias Oussedik; Jennifer J Schoch; Adam C Berger; Mauro Picardo
Journal:  J Am Acad Dermatol       Date:  2018-09-17       Impact factor: 11.527

Review 4.  Chemical Leukoderma.

Authors:  Domenico Bonamonte; Michelangelo Vestita; Paolo Romita; Angela Filoni; Caterina Foti; Gianni Angelini
Journal:  Dermatitis       Date:  2016 May-Jun       Impact factor: 4.845

5.  Chemical Leukoderma Associated with Vicks VapoRub.

Authors:  Kathryn E Boyse; Matthew J Zirwas
Journal:  J Clin Aesthet Dermatol       Date:  2008-11

6.  Vitiliginous lesions induced by amyl nitrite exposure.

Authors:  Kathleen Vine; Marc Meulener; Sherry Shieh; Nanette B Silverberg
Journal:  Cutis       Date:  2013-03

7.  Depigmenting activity and low cytotoxicity of alkoxy benzoates or alkoxy cinnamte in cultured melanocytes.

Authors:  Hak Hee Kang; Ho Sik Rho; Jae Sung Hwang; Seong-Geon Oh
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-09       Impact factor: 1.645

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.